Fresh cells, serum and MPs | Frozen serum and MPs | |
---|---|---|
SLE patients | 20 | 28 |
Age, median (range) | 45 (22–64) | 42 (22–69) |
Sex, number (%) of females | 17 (85) | 24 (86) |
Disease manifestations at study inclusion, number (%) of patients | ||
Renal disease | 2 (10) | 8 (29) |
Vasculitis | 2 (10) | 3 (11) |
Arthritis | 2 (10) | 3 (11) |
Interstitial lung disease | 1 (5) | 0 (0) |
Haemolysis | 1 (5) | 1 (4) |
Alopecia | 3 (15) | 1 (4) |
Rash | 2 (10) | 3 (11) |
Mucosal ulcers | 3 (15) | 3 (11) |
Leucopenia | 1 (5) | 1 (4) |
Serositis | 0 (0) | 1 (4) |
Thrombocytopenia | 0 (0) | 1 (4) |
SLEDAI, median (range) | 4 (0–12) | 5 (0–18) |
HCs | 10 | 11 |
Age, median (range) | 33.5 (25–63) | 34 (24–54) |
Sex, number (%) of females | 6 (60) | 9 (82) |